The widespread hypoxic conditions of the tumor microenvironment can impair the metabolism of bioessential elements such as copper and sulfur, notably by changing their redox state and, as a consequence, their ability to bind specific molecules. S-enriched by ∼1.5‰ in the blood of patients compared with that of control subjects. As expected, HCC patients have more copper in red blood cells and serum compared with control subjects. However, the isotopic signature of this blood extra copper burden is not in favor of a dietary origin but rather suggests a reallocation in the body of copper bound to cysteine-rich proteins such as metallothioneins. The magnitude of the sulfur isotope effect is similar in red blood cells and serum of HCC patients, implying that sulfur fractionation is systemic. The 32 S-enrichment of sulfur in the blood of HCC patients is compatible with the notion that sulfur partly originates from tumor-derived sulfides. The measurement of natural variations of stable isotope compositions, using techniques developed in the field of Earth sciences, can provide new means to detect and quantify cancer metabolic changes and provide insights into underlying mechanisms. stable isotopes | copper | sulfur | liver | cancer
Cu) and sulfur ( 34 S/ 32 S) in the blood of patients with hepatocellular carcinoma (HCC) as a tool to explore the cancer-driven copper and sulfur imbalances. We report that copper is 63 Cu-enriched by ∼0.4‰ and sulfur is 32 S-enriched by ∼1.5‰ in the blood of patients compared with that of control subjects. As expected, HCC patients have more copper in red blood cells and serum compared with control subjects. However, the isotopic signature of this blood extra copper burden is not in favor of a dietary origin but rather suggests a reallocation in the body of copper bound to cysteine-rich proteins such as metallothioneins. The magnitude of the sulfur isotope effect is similar in red blood cells and serum of HCC patients, implying that sulfur fractionation is systemic. The 32 S-enrichment of sulfur in the blood of HCC patients is compatible with the notion that sulfur partly originates from tumor-derived sulfides. The measurement of natural variations of stable isotope compositions, using techniques developed in the field of Earth sciences, can provide new means to detect and quantify cancer metabolic changes and provide insights into underlying mechanisms. stable isotopes | copper | sulfur | liver | cancer C opper is an essential trace element (1) , which has a pivotal role in the balance of oxidative stress: High levels are harmful because reduced copper promotes the generation of reactive oxygen species (2) , and in the meantime, copper is involved in several enzymes (ceruloplasmin, hephaestin, Cu/Zn superoxide dismutase) that prevent the generation of reactive oxygen species (e.g., ref. 3) . Three major types of ligand are associated with copper binding. Copper binds to nitrogen in histidine, and to sulfur in cysteine and methionine. Cu ratio, expressed in delta units (Method), varies between organs from −1‰ in liver to +1‰ in kidney (6) (for comparison, this ratio ranges from −3‰ to +2.5‰ in terrestrial materials). In humans, the 65 Cu/ 63 Cu ratio in blood and bone differs between men and women (7, 8) , partly because a sizeable proportion of the women's blood copper comes from the liver to balance menstrual losses (9, 10) . The body 65 Cu/ 63 Cu ratio varies according to that of diet (11) and also seems to be age dependent (12) . In life sciences, sulfur isotopic ratios are mainly used to trace animals' diet in wildlife (13) and in stockbreeding (14) contexts. To this date, one study reports on bodily sulfur isotopic systematics, which shows no significant variations relative to diet in a murine model (15) .
The natural variations of the isotopic ratios of an element offers a new means to study the imbalances linked to pathological conditions (16) (17) (18) . Here, we used the natural variations of the 
Significance
In cancer, the metabolism of copper and sulfur are dysregulated, leading to deleterious side effects. These issues are commonly addressed by studying the variations of concentrations of the elements, but here we have used, for the first time to our knowledge, copper and sulfur stable isotope compositions variations, using methods widespread in Earth sciences. We show that in hepatocellular carcinomas patients, blood copper and sulfur are enriched in light isotopes compared with control subjects. These isotopic signatures are not compatible with a dietary origin, but rather reflect the massive reallocation in the body of copper immobilized within cysteine-rich proteins such as metallothioneins. We also propose that sulfur isotope compositions could serve to track sulfur originating from tumorderived sulfides.
is the main copper reservoir in the body and is known to be a pivotal organ for the metabolism of sulfur amino acids, and because the metabolism of copper and sulfur has been shown to be disrupted in cancer (e.g., refs. 19 and 20) . To this end, we measured the δ 65 Cu and δ 34 S values in the serum and red blood cells of a series of Thai male HCC patients (n = 23, Material) and control subjects (n = 20, Material). We also analyzed biopsies of liver tumor and surrounding unaffected tissues from seven Caucasian patients (Material).
Results
Correlation of Copper and Sulfur Isotopes with Biological Parameters.
Several parameters were measured in the framework of the International Liver Cancer Study (ILCS) initiative in Thailand, including alkaline phosphatase (ALP), aspartate aminotransferase (AST), and alanine aminotransferase (ALT), which are classical tests for liver function and latent-transforming growth factor β binding-protein 2 (LTBP2), a new candidate biomarker of HCC (21) . In general, tests for liver function fail to discriminate HCC patients from controls [analysis of variance (ANOVA); ALP, P = 0.456, AST, P = 0.172, ALT, P* = 0.010], while LTBP2 values do (ANOVA; P*** < 10
−4
). In serum, copper and sulfur isotope compositions are not correlated to any of the tests for liver function (copper; ALP, R = 0.350, P* = 0.027, AST, R = 0.231; P = 0.151, ALT, R = 0.144, P = 0.379; sulfur; ALP, R = 0.219, P = 0.271, AST, R = 0.245; P = 0.218, ALT, R = 0.186, P = 0.353). Serum copper isotope compositions are not correlated to LTBP2 values (R = −0.093, P = 0.569). However, serum sulfur isotope compositions are correlated to LTBP2 values (R = −0.509, P** = 0.006), but this mostly results from a group effect between HCC patients and controls.
In serum, copper and sulfur isotope compositions are not correlated to any anthropometrical parameter i.e., age, height, and body mass index (Tables S1 and S2 ). This holds for red blood cells (RBC) too (Tables S2 and S3 ), except that an inverse correlation (R = −0.490, P* = 0.028) is observed between the age of control subjects and the copper isotope composition of RBC (Fig. S1 ), as previously observed in a remote Yakut population (12) .
Copper and Sulfur Isotopes in Blood Fractions of HCC Patients and
Control Subjects. Copper concentrations and isotope compositions were measured along with ceruloplasmin (Cp) concentrations and Cu/Zn superoxide dismutase (SOD1) activity in the blood fractions of HCC patients and control subjects. Results are given in Table S1 for serum and in Table S3 for RBC. As expected from a wealth of data (e.g., ref. 22) , copper concentrations were higher in the serum and in RBC of HCC patients compared with controls (serum, P < 10 In addition, we observed a small increase of Cp (P = 0.012, Fig. 1C ) and a decrease in SOD1 activity (P = 0.015, Fig. 1D ), two effects previously reported in a variety of cancers (23, 24) .
The copper isotope composition of blood fractions showed a tendency toward enrichment in 63 Cu in HCC patients compared with control subjects ( Fig. 1 E and F) . This effect is significant in RBC only (RBC, P < 10
, serum, P = 0.134). However, there is a generally good correlation between serum and RBC copper isotope composition in HCC patients (P < 10
, R = 0.579), suggesting that the copper isotopic imbalance is reflected in both fractions ( Fig. 2A) . We hypothesize that the lack of significant isotopic difference in the serum of HCC patients is due to the short half-life of serum copper, which is determined by that of Cp (t (26) that serum copper levels increased in various chronic diseases, including several types of cancers, resulting into a systemic and oncogenic copper accumulation (19, 27, 28) . The present isotopic copper results suggest that this extra copper burden is unlikely of exogenous (dietary) origin. Enhanced exogenous copper uptake would be expected to attenuate the isotopic fractionation between dietary sources and blood, leading the δ 65 Cu value of blood fractions to tend toward that of the diet. Such a mechanism has been proposed to explain the iron isotope composition of blood in patients with hemochromatosis (16) . Assuming that the composition of a typical human diet may give typical δ 65 Cu values of about +0.4‰ (6), enhanced dietary copper uptake would result in a 65 Cu enrichment in the blood of HCC patients, which is not compatible with our observations. If not exogenous, the extra copper burden may be caused by (i) reduced copper losses through bile and (ii) release of copper from endogenous stores.
Bile is the major normal pathway of copper excretion. The impairment of hepatic cells in HCC can lead to a reduced bile production, and consequently to an increase of systemic copper. Testing this hypothesis requires comparison of bile production and chemical composition for HCC patients and healthy controls. This approach can be easily achieved in further experiments by using murine models. Such experiments should focus on HCC models but also on other cancer models where there is, in principle, no relationship with liver function impairment. The release of copper from endogenous stores could be directly demonstrated by analyzing the copper concentration and isotope composition for various organs in cancer mice and comparing the results with control mice. Here, we use an indirect approach, which consists to predict the isotope composition of copper released from normal cells. In cells, copper is laden mainly to three metalloproteins, i.e., SOD1 and metallothionein (MT) in the cytoplasm and cytochrom c oxidase (CcO) in mitochondria (29) (30) (31) . As heavier isotopes bind preferentially with ligands with stronger electronegativity (oxygen > nitrogen > sulfur, ref. 4) , and taking the binding characteristics of the main three copper-laden proteins into account, one can predict that δ Cu value of the extra copper burden may thus be explained by the release of intracellular copper from cysteine clusters, with MT being the most likely source. Therefore, the links between copper imbalance in cancer and MT should be the focus of further attention.
A third mechanism, which is not exclusive from the previous ones, can explain the low δ 65 Cu value of the blood extra copper burden. It involves mass conservation of copper isotopes between 65 Cu-depleted blood and 65
Cu-enriched tumors. In a series of liver biopsies of HCC patients sampled along with adjacent normal liver tissues, we found that tumors are systematically 65 Cu-enriched relative to normal tissues (Table S4 and 
The observation of lower δ 34 S values in the serum and the RBC of HCC patients is unexpected because the two blood fractions have different proteomes, thereby suggesting that a common mechanism might be at work. The hypothesis of enhanced formation of sulfides, in which the δ 34 S value is 20‰ less than in coexisting sulfate (32), may be involved. Tumor-derived hydrogen sulfide (33) and allosteric formation disulfide bonds in cancer-related proteins (20) are possible candidates, but it is still unclear how prevalent is the formation of these compounds. Considering that the sulfur content of proteins is stoechiometric and therefore constant, the blood δ 34 S value of HCC patients (δ 34 S HCC = 4.0‰) can be considered as a mixture of the normal sulfur isotope composition (δ 34 S N = 5.4‰) and of total sulfides (δ 34 S TS ), with proportion x and 1 − x, respectively:
Such a simple mass balance indicates that about 6% of total sulfur in blood of HCC patients is coming from tumor produced sulfide with a δ 34 S TS of −20‰. This number decreases to 4% with a δ 34 S TS of −30‰. These numbers are very high and require further investigations, notably the direct determination of the δ 34 S value of tumor produced H 2 S. However, they already suggest that blood sulfur isotopic variations of HCC patients is a sizeable process that may provide new biomarkers for cancer detection and monitoring. However, the sulfur isotope compositions need to be measured on other types of cancer to know whether the origin of the low blood δ 34 S values in HCC patients are linked to disorders of hepatic origin or sulfides production.
Material
Study Participants. Blood samples from patients and controls from Thailand were collected in the framework of a hospital-based case−control study conducted at the Cancer Control Unit of the National Cancer Institute of Thailand (Bangkok) from April 2008 to December 2009. All cases of primary liver cancer were recruited, and matched controls were obtained from outpatient clinics. Differential diagnosis of HCC versus cholangiocarcinoma was established by a combination of clinical examination, imaging using ultrasonography, computerized tomography or Magnetic Resonance Imaging, biochemistry (alphafetoprotein and liver function enzymes testing) and histological confirmation on a small subset of patients from whom needle biopsies were available. Individuals from the reference group presented no clinical evidence of liver disease. All study participants provided informed consent, and both Thailand and international institutional review boards approved the study protocol (21, 34) .
Liver Biopsies Collection. Liver tumor and nontumor samples were collected in spring 2010 at the Paul Brousse Hospital, Centre Hépato-Biliaire, Villejuif, France, on seven patients further diagnosed for hepatocarcinoma. Copper concentrations and isotope compositions of tumor and nontumor samples are given in Table S1 .
Method
Sample Preparation for Copper Isotope Analysis. RBC and serum samples were digested by a mixture of concentrated subboiled distilled HNO 3 Tables S1 and S3 .
Copper Concentration Analysis. Copper concentrations were measured by quadrupole inductively coupled plasma mass spectrometry (Q-ICPMS) at LGLTPE using a 7500 CX quadrupole mass spectrometer (Agilent Technologies). The following operating parameters of Q-ICPMS were optimized: rf power (1,550 W), the plasma gas flow rate (15 L·min −1 ), the auxiliary gas flow rate (2 L·min −1 ), the carrier gas flow rate (0. Iron and Zn were finally eluted with 10 mL of subboiled distilled 0.5 M HNO 3 . The copper fraction was further purified using the same protocol.
Copper Isotope Analysis. Copper stable isotope compositions were determined by multicollector inductively coupled plasma mass spectrometry at Laboratoire de Géologie de Lyon (LGLTPE), using a Nu plasma 500 high-resolution double-focusing mass spectrometer (Nu Instrument) equipped with 12 Faraday detectors and with a mass resolution of 1,000. The operating conditions were: rf power (1,300 W), plasma gas flow rate (13 L·min ), and auxiliary gas flow rate (0.9 L·min
−1
). The samples were introduced by free aspiration in 0.05 M subboiled distilled HNO 3 . Instrumental mass fractionation on copper was corrected using Zn doping (Zn JMC3-0749L; Johnson Matthey) and standard-sample bracketing technique. Sample measurement solutions were diluted to match the concentration of the standard mixture (Zn 0.25 ppm to Cu 0.25 ppm). Samples were randomized during analysis, and duplicates were measured to check for systematic errors. At Isoanalytical, about 4 ± 0.1 mg amounts of blood samples were weighed into tin capsules (8 × 5 mm) and added to 10 mg of vanadium pentoxide catalyst before sealing the capsules into balls. The capsules were loaded into the 66-position autosampler on a Sercon CNS-EA elemental analyzer. The elemental analyzer was coupled to a Europa Scientific 20-20 istope ratio mass spectrometer on which the sulfur isotope analyses were performed. From the autosampler, samples dropped, in sequence, into a furnace held at 1,080°C and combusted in the presence of oxygen. Tin capsules flash combust, raising the temperature in the region of the sample to ∼1,700°C. The combusted gases are then swept in a helium stream over combustion catalysts (tungstic oxide/zirconium oxide) and through a reduction stage of high-purity copper wires to produce SO 2 , N 2 , CO 2 , and water. Water is removed using a Nafion membrane. Sulfur dioxide is resolved from N 2 and CO 2 on a packed GC column at a temperature of 32°C. The resultant SO 2 peak enters the ion source of the IRMS whereupon it is ionized and accelerated. Gas species of different mass are separated in a magnetic field and then simultaneously measured on a Faraday cup universal collector array. Analysis was based on monitoring of m/z 48, 49, and 50 of SO + produced from SO 2 in the ion source.
At LGLTPE, the EA system used is a VarioPYROcube (Elementar GmbH). As in most conventional EA-IRMS systems, the VarioPYROcube system used helium as a carrier gas and consisted of a combustion tube followed by a reduction tube. However, the chemical water trap is a SICAPENT dryer. Nitrogen gas is not trapped and goes straight through the EA system. CO 2 and SO 2 are trapped at room temperature and released at 110°C and 220°C, respectively, in separate traps. The EA system is connected online via an open split device to an IsoPrime IRMS system with a diluting system to allow high C/S ratio samples (2) . The delta value is given by δ . The "Canyon Diablo Troilite" was used as the sulfur isotope standard. The reproducibility of sulfur isotopic ratios was <0.4‰. 
